Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Sponsor

Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Spain Paseo De La Castellana 261, 28046 Madrid, Spain

About the sponsor

Research in atopic dermatitis focuses on treatment response prediction, with interest in cyclosporin optimisation and the use of genetic, kinetic, and immunological markers to guide therapy.

  • Biomarker-driven treatment selection
  • Pharmacokinetic and pharmacodynamic modelling
  • Multi-omic response prediction

The sponsor also supports personalised approaches in immune-mediated disease management, linking laboratory markers with clinical decision-making.

About Specializations

Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz runs clinical trials in conditions such as HIV infection, Acute lymphocytic leukaemia, Depression, Disease risk factor, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

11 clinical trials

Depression

Recruiting

Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Agomelatine
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

HIV infection+1

Recruiting

Study on Colchicine to Reduce Heart Artery Inflammation in HIV Patients Over 50 with High Cardiovascular Risk

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Acute lymphocytic leukaemia

Recruiting

Study on CART 19/22 T Cells and CART45RA-NKG2D Cells for Treating Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Cart 19/22 T Cells
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Acute lymphocytic leukaemia

Not yet recruiting

Study on the Safety and Feasibility of CART 19/22 T Cells and CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Cart 19/22 T Cells
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Giardiasis

Not yet recruiting

Study Comparing Mepacrine and Metronidazole for Treating Resistant Giardiasis in Children Aged 1 to 18 Years

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Mepacrine
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Pneumonia bacterial+1

Not recruiting

Study evaluating blood biomarkers for diagnosis and monitoring treatment in patients with pulmonary tuberculosis using isoniazid, rifampicin, pyrazinamide, and ethambutol combination

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Isoniazid
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Renal transplant

Not recruiting

Study to Evaluate the Effectiveness of Pre-emptive Genotyping to Optimize Tacrolimus Dosage in Patients with Chronic Kidney Disease Awaiting Transplant

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tacrolimus
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

HIV infection

Not recruiting

Study on Metformin for Reversing Accelerated Aging in People Aged 50+ Living with HIV

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Metformin Hydrochloride
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Ischaemic stroke

Not recruiting

Study on the Safety of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Patients with Acute Ischemic Stroke

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Adipose-Derived Mesenchymal Stem Cells Expanded
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Cardiovascular disorder

Not recruiting

Study on the Effectiveness and Safety of Atorvastatin, Simvastatin, and Fluvastatin in Patients at Risk of Cardiovascular Disease

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Dermatitis atopic

Not recruiting

Study on Optimizing Ciclosporin Treatment for Moderate to Severe Atopic Dermatitis in Adults, Adolescents, and Children

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ciclosporin
  • Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.